These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4652219)

  • 1. [A case of maple syrup urine disease. Biochemical study].
    Lamedica GM; Fregonese B; Moroni G; Famularo L
    Minerva Pediatr; 1972 Dec; 24(43):2143-9. PubMed ID: 4652219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical studies in a patient with maple syrup urine disease (author's transl)].
    Vaca G; Rivas F; Sánchez-Corona J; Olivares N; Aguirre-Negrete MG; González-Quiroga G; Medina C; Hernández A; Cantú JM
    Rev Invest Clin; 1981; 33(4):379-82. PubMed ID: 7330511
    [No Abstract]   [Full Text] [Related]  

  • 3. Transaminations between amino acids and keto acids elevated in phenylketonuria and maple syrup urine disease.
    Lees GJ; Weiner N
    J Neurochem; 1973 Feb; 20(2):389-403. PubMed ID: 4698286
    [No Abstract]   [Full Text] [Related]  

  • 4. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maple syrup urine disease.
    Voyce MA; Montgomery JN; Crome L; Bowman J; Ireland JT
    J Ment Defic Res; 1967 Dec; 11(4):231-8. PubMed ID: 5582924
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the branched-chain alpha-keto acids accumulating in maple syrup urine disease on S100B release from glial cells.
    Funchal C; Tramontina F; Quincozes dos Santos A; Fraga de Souza D; Gonçalves CA; Pessoa-Pureur R; Wajner M
    J Neurol Sci; 2007 Sep; 260(1-2):87-94. PubMed ID: 17499767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino acid analyses in two cases of maple syrup urine disease.
    Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Branched-chain alpha-keto acids isolated as oxime derivatives: relationship to the corresponding hydroxy acids and amino acids in maple syrup urine disease.
    Lancaster G; Mamer OA; Scriver CR
    Metabolism; 1974 Mar; 23(3):257-65. PubMed ID: 4813956
    [No Abstract]   [Full Text] [Related]  

  • 10. Maple syrup urine disease--a case report.
    Reddy V; Reddy YR; Rao BS; Sivakumar B
    Indian Pediatr; 1972 Oct; 9(10):629-33. PubMed ID: 4657784
    [No Abstract]   [Full Text] [Related]  

  • 11. Further observations on the biochemical lesion in maple syrup urine disease.
    Dreyfus PM; Prensky AL
    Nature; 1967 Apr; 214(5085):276. PubMed ID: 6034241
    [No Abstract]   [Full Text] [Related]  

  • 12. Maple syrup urine disease: alpha-ketoisocaproate decarboxylation activity in different types of cultured amniotic fluid cells.
    Wendel U; Gamm G; Claussen U
    Prenat Diagn; 1981 Oct; 1(4):235-40. PubMed ID: 7346826
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hereditary metabolic diseases: maple syrup disease].
    Berger R; Broyer M
    Presse Med (1893); 1968 Jul; 76(30):1531-2. PubMed ID: 5686194
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term dietetic treatment of valine-leucinuria (maple syrup urine disease)].
    Schmidt GW
    Z Kinderheilkd; 1967; 99(4):273-88. PubMed ID: 5586379
    [No Abstract]   [Full Text] [Related]  

  • 15. Maple syrup urine disease: membrane amino acid transport in non-brain tissues revisited.
    de Céspedes C
    Mol Genet Metab; 2013 Mar; 108(3):201-2. PubMed ID: 23411046
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and biochemical observations on an apparently nonfatal variant of branched-chain ketoaciduria (maple syrup urine disease).
    MORRIS MD; LEWIS BD; DOOLAN PD; HARPER HA
    Pediatrics; 1961 Dec; 28():918-23. PubMed ID: 14476272
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical studies on a variant of branched chain ketoaciduria in a 19-year-old female.
    Fischer MH; Gerritsen T
    Pediatrics; 1971 Nov; 48(5):795-801. PubMed ID: 5125877
    [No Abstract]   [Full Text] [Related]  

  • 18. Amino acids levels and lipid peroxidation in maple syrup urine disease patients.
    Barschak AG; Sitta A; Deon M; Busanello EN; Coelho DM; Cipriani F; Dutra-Filho CS; Giugliani R; Wajner M; Vargas CR
    Clin Biochem; 2009 Apr; 42(6):462-6. PubMed ID: 19121297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maple syrup urine disease: report of a case.
    Rao GP; Ramanamurthy PS; Ghafoorunnisa ; Rafeeq MR; Pathak R
    Indian Pediatr; 1974 Aug; 11(8):585-7. PubMed ID: 4443061
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acute neonatal case of maple syrup urine disease].
    Spennati G; Antonozzi I; Giardini O; De Matteis F; Cantani A; Martino F
    Minerva Pediatr; 1980 Jan; 32(1):65-70. PubMed ID: 7254143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.